alexa Bladder Management In Multiple Sclerosis | 7622
ISSN: 2161-069X

Journal of Gastrointestinal & Digestive System
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Share This Page

Bladder management in multiple sclerosis

World Congress on Gastroenterology & Urology

Fary Khan

Key Note Forum: J Gastrointest Digest Sys

DOI: 10.4172/2161-069X-S1.01

Abstract
Multiple sclerosis (MS) affects approximately 2.5 million people worldwide. These persons form a heterogeneous clinical group with respect to age, stage and severity of MS with a range of combination of disabilities (function) and participatory restriction within varying social environments and support structures. This presentation will outline management of neurogenic bladder in persons with MS. Findings from a number of research projects conducted at the MS Rehabilitation program at the Royal Melbourne Hospital (RMH) Australia will be presented. These projects address a range of methodological problems in conducting research in MS rehabilitation programs relevant to bladder and bowel care, and their solutions. These include issues of randomized trials and other study designs in MS programs, value of observational studies, clinical practice improvement programs, individualized goal attainment processes and issues of outcome measurement. In addition results of systematic reviews for efficacy of rehabilitation input for bladder care in persons with MS will be presented. The evidence to support bladder rehabilitation in the context of randomized controlled trial and sexual dysfunction will be addressed in clinical settings.
Biography

A/Prof Fary Khan is a Principal Fellow at the Department of Medicine, University of Melbourne and Director of Rehabilitation at The Royal Melbourne Hospital Australia. She completed her specialist training with the Australasian Faculty of Rehabilitation Medicine, Royal Australasian College of Physicians in 2000 and her Doctoral thesis (Title: Rehabilitation for Multiple sclerosis) in 2008 at the University of Melbourne. Her interests include: Women’s health, Outcome measurement in rehabilitation. She has published over 100 scientific papers in peer reviewed journals. She is coordinating editor of the Cochrane Multiple Sclerosis Review group (2009) and Executive Committee member AFRM for the International Classification of Disability, Health and Functioning, WHO (2006).

Top